New Jersey S2313 prohibits the sale of tetrahydrocannabinol products unless licensed and compliant with regulations.
New Jersey S2313 restricts the sale of tetrahydrocannabinol products, including delta-8, delta-9, and delta-10 tetrahydrocannabinol, to licensed entities. The sale of these products must comply with manufacturing, laboratory testing, and packaging standards set by the Cannabis Regulatory Commission. The bill also prohibits selling tetrahydrocannabinol products to individuals under 21 years old. Violations may result in civil penalties or fines.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.